These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2622073)

  • 21. [Correlation between plasma IgE and IgA in infant nephrosis and nephrotic syndrome].
    Guerra A; Cappellini T; Chiossi C; Bonvini G; Lalla M; Genova R
    Pediatr Med Chir; 1982; 4(4):425-34. PubMed ID: 7170216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimal change glomerulonephritis and focal glomerulosclerosis markers and 'in vitro' activity of peripheral blood mononuclear cell.
    Dall'Aglio P; Chizzolini C; Brigati C
    Proc Eur Dial Transplant Assoc; 1983; 19():673-8. PubMed ID: 6348758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cell-mediated immunity in the pathogenesis of the nephrotic syndrome caused by glomerulopathy with minimal histological lesions].
    Zucchelli P; Cagnoli L
    Minerva Nefrol; 1982; 29(1):3-10. PubMed ID: 7099481
    [No Abstract]   [Full Text] [Related]  

  • 24. Impaired delayed hypersensitivity in lipoid nephrosis.
    Matsumoto K; Osakabe K; Katayama H; Okano K; Watanabe S; Hatano M
    Nephron; 1984; 37(4):273-5. PubMed ID: 6462316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Various indices of cellular and humoral immunity in patients with chronic glomerulonephritis].
    Belovezhdov N; Altynkova I
    Ter Arkh; 1981; 53(12):78-82. PubMed ID: 6977884
    [No Abstract]   [Full Text] [Related]  

  • 26. Natural killer activity and antibody-dependent cell-mediated cytotoxicity in primary glomerular diseases.
    Dohi K; Yamada H; Takai M; Fujii Y; Ishikawa H
    Clin Nephrol; 1987 Jan; 27(1):11-4. PubMed ID: 3493102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired local graft-versus-host reaction in lipoid nephrosis.
    Matsumoto K
    Nephron; 1982; 31(3):281-2. PubMed ID: 6981777
    [No Abstract]   [Full Text] [Related]  

  • 28. [Two-color immunofluorescence and flow cytometry analysis of lymphocytes in minimal change nephrotic syndrome].
    Yamada H; Dohi K; Morita H; Hirayama T; Takai M; Fujii Y; Ishikawa H; Iwaki K
    Nihon Jinzo Gakkai Shi; 1987 Jun; 29(6):675-86. PubMed ID: 3500337
    [No Abstract]   [Full Text] [Related]  

  • 29. [The significance of immunologic mechanisms in the pathogenesis of renal diseases. 2. Immune complex nephritis, cell mediated reactions, pyelonephritis, therapeutic possibilities and conclusions].
    Ludwig H; Schernthaner G
    Med Klin; 1978 May; 73(19):691-703. PubMed ID: 349332
    [No Abstract]   [Full Text] [Related]  

  • 30. T cell subsets in glomerulonephritis.
    Lin CY; Yang YM; Fu YK
    Int J Pediatr Nephrol; 1986; 7(2):63-8. PubMed ID: 3487514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunological and clinical studies on the detection of immune reactivity in childhood with special reference to selected disease groups. 3. Immunologic studies in patients with kidney diseases].
    Eggers G; Wigger M; Stolpe HJ
    Padiatr Grenzgeb; 1985; 24(4):283-8. PubMed ID: 4034211
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunomorphologic comparisons in glomerulonephritis].
    Doretskiĭ VV; Bozhko EG; Zolotkovskaia OZ
    Vrach Delo; 1989 Jun; (6):32-5. PubMed ID: 2789451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-T cell antibodies in primary glomerulonephritis.
    Nakabayashi K; Arimura Y; Yoshida M; Nagasawa T
    Clin Nephrol; 1985 Feb; 23(2):74-80. PubMed ID: 3872758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mononuclear cell subsets in human renal disease. Enumeration in tissue sections with monoclonal antibodies.
    Stachura I; Si L; Madan E; Whiteside T
    Clin Immunol Immunopathol; 1984 Mar; 30(3):362-73. PubMed ID: 6607801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrotic syndrome secondary to intrinsic renal disease.
    Beathard GA
    Tex Med; 1974 Sep; 70(9):71-9. PubMed ID: 4853324
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence for cell-mediated immunity to renal antigens in minimal-change nephrotic syndrome.
    Eyres K; Mallick NP; Taylor G
    Lancet; 1976 May; 1(7970):1158-9. PubMed ID: 58202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular permeability increasing factor (VPF) in IgA nephropathy.
    Bakker WW; Beukhof JR; van Luijk WH; van der Hem GK
    Clin Nephrol; 1982 Oct; 18(4):165-7. PubMed ID: 7140031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A histological study of idiopathic nephrotic syndrome--localization of IgM in the glomeruli].
    Akano N; Uraoka Y; Tohda M; Miyamoto H; Iseki T; Takemura T; Maki S
    Nihon Jinzo Gakkai Shi; 1985 Feb; 27(2):235-42. PubMed ID: 4021187
    [No Abstract]   [Full Text] [Related]  

  • 39. Impaired IgG synthesis in patients with the nephrotic syndrome.
    Heslan JM; Lautie JP; Intrator L; Blanc C; Lagrue G; Sobel AT
    Clin Nephrol; 1982 Sep; 18(3):144-7. PubMed ID: 7140027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lymphocyte sensitization to kidney antigens in patients with Bright disease, lupus nephritis and kidney amyloidosis].
    Savitskiĭ SN; Osipova IN; Mukhin NA; Tareeva IE
    Vrach Delo; 1983 Jun; (6):35-8. PubMed ID: 6604996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.